The U.S. government announced Friday the selection of three “next generation” COVID-19 vaccine candidates, awarding millions of dollars to support mid-stage clinical trials of the shots as part of the Project NextGen initiative.
Launched in May by the Department of Health and Human Services, Project NextGen is designed to advance new COVID therapies and serve as a successor of sorts to “Operation Warp Speed,” which helped bring the first coronavirus vaccines to market.
